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Quality of Life in Obstructive Sleep Apnea
Obstructive sleep apnea (OSA) is associated with signiﬁcant cardiovascular and 
cerebrovascular morbidity and mortality. Usual parameters studied in sleep laboratory 
are unable to measure overall impact of OSA on human life. Consequently, it is 
important to measure Quality of Life (QoL) in OSA. QoL can be measured with generic 
instruments like SF-36 or OSA speciﬁc questionnaires like Calgary Sleep Apnea 
Quality of Life (SAQLI) questionnaire. Most of the studies suggest that there is 
signiﬁcant impairment of QoL in patients of OSA. But the present evidence suggests 
that impairment in QoL is not proportional to severity of OSA. There is no consensus on 
the question of improvement in QoL with Continuous Positive Airway Pressure 
(CPAP) therapy. A recent Cochrane review concluded that CPAP improves QoL in 
people with moderate and severe OSA.
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S l e e p  a p n e a  i s  d e ﬁ n e d  a s 
repetitive episodes of decreased or total 
cessation of respiratory airﬂow during 
sleep, leading on to desaturation and sleep 
fragmentation. There are two types of 
sleep apnea - OSA and Central Sleep 
Apnea.  In  OSA the  cessa t ion  of 
respiration during sleep is caused by upper 
respiratory obstruction and the apnea is 
followed by strenuous breathing effort.
The site of occlusion varies, and it 
can occur at several levels or at various 
sites during different stages of sleep. Any 
disorder that produces or contributes to 
upper airway narrowing is a risk factor for 
OSA, including obesity, enlarged tonsils, 
anatomical  malformations of  the 
jaw/pharynx and pharyngeal muscle 
weakness caused by neuromuscular 
disorders. When the OSA is accompanied 
by daytime sleepiness, it is referred to as 
the OSA syndrome(OSAS)(1).
In a population based study of 
employed adults between 30 and 60 years 
of age in the western world, the prevalence 
of OSA (which was deﬁned as at least ﬁve 
apneas and hypopneas per hour of sleep 
accompanied by excessive daytime 
sleepiness) was 4% for males and 2% for 
females (2). Indian prevalence studies 
estimated disease prevalence rates of 3.5-
13.7% (4.4-19.5% in males and 2.5-7.4% 
in females) (3,4,5,6). Prevalence of OSAS 
in India is 1.7-3.6% (2.4-7.5% in males 
and 1-2.1% in females). Although the 
number of OSA prevalence studies in 
India is not sufﬁcient and there is major 
difference in the prevalence among 
different studies but all the studies 
indicate that it is an important public 
health concern in India also.
Research on sleep-disordered 
breathing,  including s leep apnea 
syndromes, has grown tremendously in 
recent years. Many studies have indicated 
an association between sleep apnea and 
cardiovascular / cerebrovascular related 
morbidity and mortality (7,8). Sleep 
apnea has also been linked to an increased 
risk of road accidents and changes in 
personality. These symptoms have been 
attributed to nocturnal oxyhaemoglobin 
desaturation and to the chronic sleep 
d e p r i v a t i o n  c a u s e d  b y  s l e e p 
fragmentation. Even patients with 
comparatively mild OSA with Apnea-
Hypopnea Index (AHI) < 20 report 
impairment in social functioning, and 
limitations in function because of physical 
and emotional factors, as well as a lowered 
sense of well being for mental health and 
energy than in normal subjects (9). 
With successful treatment, quality 
of life may improve with nasal continuous 
positive airway pressure (nasal CPAP). 
However, so far, disease severity prior to 
nasal CPAP treatment does not clearly 
relate to post-treatment improvements in 
health related QoL (10). Conventionally, 
the impact of the disease in OSA cases is 
often measured in term of physiological 
response on control sleep recordings and 
severi ty  of  symptoms.  But  these 
s y m p t o m a t i c  m e a s u r e s  a n d  t h e 
physiological scales e.g. AHI have failed 
to measure adequately the rather broader 
impact of the disorder on human life. As 
symptoms are usually a subset of overall 
QoL of patient, it is important to measure 
overall impact of the disease on life per se. 
Several researchers have highlighted the 
importance of measuring QoL in OSA 
patients (11).
Measuring Quality of life in OSA :
 Health Related Quality of Life 
(HRQoL) is a concept developed on the 
lines of the WHO deﬁnition of health 
(including physical, emotional, social and 
spiritual well being) by including both 
personal health status and social well 
being when assessing health. HRQoL is 
evaluated subjectively; that means it is 
assessed by the person himself and it is 
evaluated with the help of Questionnaires. 
These Questionnaires have multiple 
domains representing different aspects of 
life. There are two types of Questionnaires 
which can be used to measure QoL in 
patients of OSA. (Table 1)
1) Generic Questionnaires – These 
Questionnaires can be used to measure 
QoL in all kind of clinical conditions.
2) OSA Speciﬁc Questionnaires – These 
Questionnaire can be used to determine 
QoL in OSA patients only. 
Which type of Questionnaire should be 
used for measuring QoL :
Generic and the OSA speciﬁc 
Questionnaires have different advantages 
and disadvantages. The structure of 
G e n e r i c  q u e s t i o n n a i r e s  i s  m o r e 
comprehens ive .  They  can  a l low 
comparison between studies, populations, 
or diseases but they may have some 
domains which are not related to OSA. 
Thus they may be less sensitive as 
compared to the disease speciﬁc 
Questionnaires (12). In case a person is 
suffering from more than one disease, 
Generic Questionnaires are more 
appropriate. 
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Table 1- List of Generic and OSA speciﬁc QoL Questionnaires
Generic Questionnaires
MOS(Medical Outcome Survey)
SF-36(Short Form-36)
NHP (Nottingham Health Proﬁle)
EuroQoL
SIP (Sickness Impact Proﬁle )
MLDL(Munich Life Quality Dimension List)
OSA Speciﬁc Questionnaires
Calgary SAQLI ( Sleep Apnea 
Quality of Life Questionnaire)
FOSQ (Functional Outcome of 
Sleepiness Questionnaire)
QSQ (Quebec Sleep Questionnaire)
OSAPOSI (OSA Patient Oriented 
Severity Index)
Disease speciﬁc questionnaires 
are more sensitive to detect subtle changes 
in QoL in patients having that disease. 
These questionnaires have Questions 
related to the disease so these tend to have 
higher acceptability and completion rates. 
But disease speciﬁc Questionnaires don't 
allow inter disease comparisons.
Thus, the choice of Questionnaire 
should be based on research question. If 
the researcher wants to compare QoL 
among two conditions then obviously 
only generic questionnaires can be used. 
Otherwise the recent trend is towards use 
of OSA speciﬁc questionnaires because of 
their better acceptability and completion 
rates.
Discussion :
The symptoms of OSA have been 
recognized for many years. Interestingly, 
the ﬁrst observation of disease was not 
made by a physician but a famous writer. 
Charles Dickens described an obese, 
hypersomnolent boy in his novel “The  
Posthumous Papers of the Pickwick Club" 
where he wrote "... and on the box sat        
a fat and red faced boy, in a state of 
somnolency" or "Joe damn that boy, he's 
gone to sleep again" is a classic portrayal 
of an OSA patient (13). William Osler, 
who was a famous physician of early 20th 
Century also observed the association of 
obesity and hypersomnolence when he 
described the obesity-hypoventilation 
syndrome or Pickwickian syndrome in 
1918 (14). Despite the description of these 
observations and associations, it was only 
in 1973 that Guilleminault described the 
disease as obstructive sleep apnea 
syndrome (15). Subsequently several 
r e p o r t s  a p p e a r e d  r e g a r d i n g 
pathophysiology, diagnosis and treatment 
of OSA. Although OSA is relatively 
recent disease as far as the discovery is 
concerned, it is a disease with high 
prevalence and carries signiﬁcant 
morbidity associated with it.
Like any other chronic medical 
conditions OSA also impair normal 
human life extent of which can be 
measured quantitatively in form of 
HRQoL index. Various scales such as the 
Nottingham Health Proﬁle and SF 36 have 
been used in patients with OSA to evaluate 
the QoL. Measurement of QoL has 
become an important part of management 
of patients with OSA.
Although WHO recognised as early 
as in 1947 that health encompassed 
physical, mental and social well being, the 
use of QoL measurement started mostly in 
1980s (16). QoL measurement was even 
more appropriate in case of OSA as AHI, the 
index of OSA severity, was inadequate in 
measuring the overall impact of OSA on 
human life. The First study of QoL in OSA 
was published by Gall et al which used SF-
36 questionnaire to measure QoL (9). The 
study recruited 42 males and the researchers 
observed that QoL was signiﬁcantly 
impaired in OSA patients. Interestingly in 
some severe OSA patients there was little 
impairment of QoL. After that there have 
been many studies exploring QoL in 
p a t i e n t s  o f  O S A w h i c h  h a s  b e e n 
summarised in table-2. The initial studies 
used only generic instruments to measure 
HRQoL in these patients. In 1998 Flemons 
et al in their instrument validation study 
used Calgary SAQLI, an OSA speciﬁc 
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Questionnaire to measure QoL in OSA 
patients (17). After this other OSA speciﬁc 
Questionnaires like Functional Outcome of 
Sleepiness Questionnaire (FOSQ), OSA 
P a t i e n t  O r i e n t e d  S e v e r i t y  I n d e x 
( O S A P O S I )  a n d  Q u e b e c  S l e e p 
Questionnaire (QSQ) have also been used. 
Among the Generic Questionnaires SF-36 
has been used most. Jenkinson et al. used 
SF-36 to assess QoL and observed that there 
is signiﬁcant deterioration of QoL in 
patients of OSA and it improved with CPAP 
treatment. The generic instruments studies 
have shown signiﬁcant variability in QoL 
assessment even among same patients (18). 
Jenkinson et al used SF-36, respiratory 
disturbance index (RDI) and EuroQoL 
among same group of OSA patients and 
observed that while SF-36 and PGI showed 
signiﬁcant life impairment in OSA, in 
contrast to the EuroQoL, which showed 
little QoL impairment (19).
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Table 2 – Summary of studies exploring QoL in OSA
Study Sample size AHI Instrument used Setting Observation
Gall et al. 
(1993)(9)
Fornas et 
al. (1995)
(20)
Bolitschek
 et al. 
(1998) 
Jenkinson
 et al. 
(1998)(18) 
OSA patients 
= 42 (All 
Males)
OSA Patients
= 103
Healthy 
controls= 40
OSA patients 
treated with 
CPAP=21
Untreated OSA 
patients = 21
Healthy controls
=113
n = 89 for PGI 
and EuroQol,
n= 86 for SF-36
AHI
38+ 27
47.08/49.94
(Treated/
Untreated)
SF-36
NHP
MLDL
PGI,
EuroQoL
SF-36
Untreated
Untreated
Untreated
Before and 
after 3 months 
CPAP
Mild OSA patients had 
impairment in Social 
Functioning, Role 
Limitations-Physical and 
Emotional, lowered mental 
health and well-being.
SAHS patients showed a 
deterioration of general 
health status parameters in 
comparison with healthy 
subjects, these parameters 
do not correlate with the 
physiological disturbances 
of SAHS, expressed as the 
number of respiratory 
events per hour
OSA patients treated with 
CPAP had 'life satisfaction' 
ratings comparable to that 
of the healthy controls. 
Untreated OSA patients 
had impairment in all 4 
domains of MLDL.
Before CPAP SF-36 scores 
were low which increased to 
levels similar to general 
population after 3 months of 
CPAP therapy. Change in 
EuroQol scores were not 
signiﬁcant. The PGI scores 
in accordance with SF-36 
scores showed substantial 
improvement after CPAP.
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Study Sample size AHI Instrument used Setting Observation
Piccrillo 
et al. 
(1998)
Flemons 
et al. 
(1998) 
SAQLI was 
tested in 24 
OSA patients. 
N.A. SAQLI SF-36 Before starting 
and 4 week after 
CPAP
Bennett 
et al. 
(1999) 
 51 OSA 
patients (46 M 
and  5 F)
Median 
apnea/
hypopnea 
index [AHI] 
25, 90% 
central 
range: 
1 to 98
SF-36 Before and after 
4 week CPAP
D'Ambrosio 
et al. 
(1999) 
OSA patients = 
29 (23 M, 6 F)
77 + 9 SF-36 8 week CPAP
Engleman 
et al. 
(1999)  
OSA patients = 
34 (21 M, 13 F)
Cross over trial- 
patients on 4 
weeks of CPAP 
and 4 weeks of 
oral placebo 
therapy 
alternatively
Mild sleep 
apnea patients 
(5-15)
NHP     SF-36 Before and after 
4 week CPAP or
 oral placebo
119 OSA 
patients- 71 
given CPAP, 
48 underwent 
surgery
Mean= 
40.0
SF-36, 
OSAPOSI
Before and 
after 
CPAP/Surgery
 Scores on the role-physical, 
vitality, and emotional 
wellbeing subscales of the 
SF-36 increased signiﬁcantly.  
OSAPOSI awake and sleep 
subscales and total 
instrument score increased
SAQLI had a high 
correlation with SF-36  
among patients successfully 
completing CPAP
In OSA patients SF-36 
subscale scores for 
role-physical and vitality 
were impaired prior to 
CPAP as compared to normal 
population, which improved 
to normal levels after CPAP 
therapy.
All domains of SF-36 were 
impaired in OSA patients 
when compared with an age 
and sex matched population. 
Eight weeks of treatment 
improved Quality of life to 
the level of normal 
population. Improvement 
was maximum in domains 
of vitality, social functioning
 and mental health. 
In OSA patients SF-36 
scores were impaired on all 
subscales except general 
health perceptions. After 
CPAP treatment, signiﬁcant
 improvements were seen in
general health, role-phy ical, 
bodily pain, social
functioning, and vitality. 
Social functioning and vitality
were signiﬁcantly greater on 
CPAP than on placebo. There 
was no change in QoL after 
CPAP therapy on NHP for 
health and functional status.
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Study Sample size AHI Instrument used Setting Observation
Yang et 
al. (2000)
(25)
Stepnowsky 
et al. (2000)
(26)
Walker- 
Engstrom 
et al. 
(2000) (27)
Baldwin 
et al. 
(2001)(28)
Akashiba 
et al. 
(2002) (29)
OSA patients
-37
Controls- 46
n = 69 
(29 M, 40 F)
84 OSA 
patients- 41 in 
oral appliance 
group 43 in 
UPPP group
2398 OSA 
patients
5-14 AHI=1473
15+= 916
60 OSA patients,
34 healthy 
controls(entry 
criteria AHI > 
20/h and severe 
arterial oxygen 
desaturation 
(arterial oxygen 
saturation [Sao ] 
2
< 80%) 
accompanied 
by EDS
22 ± 19 
51.6 ± 26.6
SF-36
MOS
QWB
MSE-P
SF-36
SF-36
Untreated
Untreated
Before and 
1 year after 
UPPP or dental 
Device
Untreated
Untreated
After controlling for age, 
gender, body mass index, 
and number of comorbid 
conditions, the association 
between sleep apnea and 
QOL was signiﬁcant in the 
domains of physical 
functioning and role 
limitation due to physical 
health problems and was 
borderline in vitality.
OSA patients with RDI< 15 
had signiﬁcant impairment in 
general physical functioning 
and mental health functioning 
(not those with RDI>15).
The mean values for the three 
dimensions vitality, contentment 
and sleep improved signiﬁcantly 
1 year after intervention in the 
dental appliance and UPPP 
groups. One year after  
intervention the UPPP group
showed signiﬁcantly more 
contentment than the dental 
appliance group. In contrast,
vitality and sleep dimensions 
did not differ between the two 
treatment groups. No signiﬁcant
 correlations were observed 
between the QOL scores and
 somnographic values.
Sleep disturbances are 
associated with worse physical 
and better mental HR-QOL 
than the U.S. norm.
Six of eight domains and the 
total score on the SF-36 were 
signiﬁcantly lower than those 
in the control subjects.
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Most of the studies suggest that 
there is signiﬁcant impairment of QoL in 
OSA patients but interestingly the QoL 
impairment has not been found to be 
directly proportional with the severity of 
OSA as determined by AHI (10, 20, 25). 
Only Indian study conducted on this issue 
also observed signiﬁcant impairment of 
QoL in OSA and no association of severity 
of impairment with severity of OSA (31). 
No other polysomnographic variable has 
also been consistently found to be 
associated with QoL impairment. It has 
been suggested that HRQoL deteriorates 
only to a certain level with increasing 
RDI, but then plateaus (32).
The question of effect of CPAP 
treatment on QoL in OSA patients has not 
been answered convincingly. Different 
studies have shown divergent results. 
Some studies have shown that CPAP 
treatment improves QoL so much so that it 
reaches the level of healthy controls but 
some studies did not observe signiﬁcant 
improvement in QoL. In many CPAP trials 
the issue of compliance has not been 
addressed properly and proper adjustment 
to take compliance has not been done. A 
2006 Cochrane review on Continuous 
positive airways pressure for OSA in 
adults concluded that CPAP improves 
QoL in people with moderate and severe 
OSA (33). 
Thus, it is important to measure 
QoL in patients of OSA as it gives the clear 
picture of sufferings of the patients and 
helps in formulating holistic treatment 
strategy.
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Study Sample size AHI Instrument used Setting Observation
Glebocka 
et al. 
(2006)(30) 
Dutt et al.
(2013)(30) 
29 OSA patient, 
34 healthy 
controls
69 OSA 
patients
(57 M+12 F)
41 healthy 
controls
33.3 ±15.8
26.39 ±16.62
Satisfaction With 
Life Scale 
(SWLS)
SAQLI
Untreated
Untreated
No difference in satisfaction 
with life score between OSA 
patients and Controls.
QoL was impaired in OSA 
patients in all the four domains 
of Calgary SAQLI. QoL 
impairment not directly 
proportional to severity of OSA.
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